Differences between the different conditioning regimens for allogeneic stem cell transplantation
Authors:
- Anton Vmb SchattenbergASAnton Vmb Schattenberg
- Tjakiena H LevengaTLTjakiena H Levenga
- 1 November 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Oncology
- Vol. 18 (6) , 667-670
Abstract
The aim of this article is to compare the differences in efficacy and toxicity between the various conditioning regimens for allogeneic stem cell transplantation. Several studies, all retrospective, that compare the impact of various different conditioning regimens amongst each other are presented. Reduced intensity conditioning apparently lowered transplant-related mortality in patients with minimal residual disease who were at high risk for treatment-related mortality. In contrast, patients with active disease could only be salvaged when a myeloablative conditioning regimen was used. By consequence, it was concluded that patients without contraindications for a myeloablative conditioning regimen should not receive reduced regimens outside a prospective randomized trial. Despite high expectations, non-myeloablative conditioning regimens and regimens that have been reduced in intensity did not prove to be superior in survival when the outcomes were compared with those obtained with conventional myeloablative conditioning. Randomized prospective studies are needed to explore the appropriate niche for the various different regimens.Keywords
This publication has 12 references indexed in Scilit:
- Allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning as treatment for hematologic malignancies and inherited blood disordersMolecular Therapy, 2006
- Myeloablative allogeneic hematopoietic stem cell transplantation in elderly patientsClinical Transplantation, 2006
- Reduced Intensity vs Myeloablative Conditioning for HLA Matched Sibling Transplantation in Follicular Lymphoma.Blood, 2005
- Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of ageBlood, 2005
- Conventional versus reduced‐intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignanciesEuropean Journal of Haematology, 2005
- Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioningBlood, 2004
- Induction of graft-versus-leukemia to prevent relapse after partially lymphocyte-depleted allogeneic bone marrow transplantation by pre-emptive donor leukocyte infusionsLeukemia, 2001
- Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effectsBlood, 2001
- Non-Myeloablative Transplants for Malignant DiseaseHematology-American Society Hematology Education Program, 2001
- One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantationBlood, 1977